Bob Blancato on Exchanges

As reported in the June 11, 2014 Avalere study examining cost sharing in silver exchange plans, many drugs for patients with chronic conditions enrolled in silver exchange plans are priced as to be unaffordable, creating access barriers for many patients for whom the landmark Affordable Care Act was particularly designed. This study exposes a genuine flaw in a key part of the Act which especially impacts the 25 percent of enrollees in exchanges who are between the ages of 55 and 64. People as they age find their prescription drug costs rise, in part due to increases in chronic conditions.

Bob Blancato
,


Lawrence A. LaMotte - high out-of-pocket costs

Lawrence A. LaMotte
,


Brian Hujdich - high out-of-pocket costs

Virginia Ladd - high out-of-pocket costs

Carl Schmid - high out-of-pocket costs

John Rice
,


Select a Contributor Response

Conversations:

How are patients with chronic conditions who have exchange coverage affected by high out-of-pocket costs for medicines?

View All Conversations

 

How are patients with chronic conditions who have exchange coverage affected by high out-of-pocket costs for medicines?

Test Name
Test Title, Test Company

Read biography×
This is a test modal

Margaret Barton-Burke on Exchanges

Submitted by Julie on

The dramatic cost shifting to vulnerable populations that is taking place within the Health Insurance Exchanges is troubling. The Oncology Nursing Society (ONS) believes that access to cancer care is the right of all people. While the Affordable Care Act (ACA) expanded access to insurance coverage, unaffordable co-insurance payments continue to threaten access to cancer care.

Pages

Subscribe to PhRMA RSS